MAXYGEN INC MAXY (NASDAQ)

$ 4.37
19:09
Change: -0.13 (-2.89%)
Volume: 93,900

Avg. Volume: 141445
P/E Ratio: 0
EPS (Annual): -1.84
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 37,050
Institutional Shareholders: 58.59%
Last: 4.37
Change: -0.13 (-2.89%)
Prev. Close: 4.50
Open: 4.50
Day's Range: 4.29 - 4.50
52wk Range: 3.28 - 8.94
Market Value: 167,060
Beta: 1.5
12-month EPS Change: 0.00%
Total Return Last 12 Months: -47.98%
Total Return Last 3 Years: -56.55%
Total Return Last 5 Years: -64.41%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on MAXY
Alert me Subscribe

Maxygen shares jump on Bayer hemophilia deal

(NEW YORK)Shares of Maxygen Inc. jumped Wednesday after the biotechnology company said it is selling its hemophilia treatment program to Bayer's health care division for $90 million, plus up...READ MORE
Jul 02, 2008 6:10PM
Keywords: MAXY, NVO, BAX, WYE

Movers roundup: J.M. Smucker, Maxygen

Among the stock activity stories for Wednesday, July 2, from AP Financial News: NEW YORK (AP)--Shares of jams and jellies maker J.M. Smucker Co. jumped Wednesday after a Deutsche B...READ MORE
Jul 02, 2008 2:43PM
Keywords: SJM, DB, MAXY, CHK, PXP

Maxygen selling hemophilia unit to Bayer

(NEW YORK)Bayer's health care unit is buying Maxygen Inc.'s hemophilia unit for $90 million upfront and potential future fees of up to $30 million in a move to expand its specialty pharmaceu...READ MORE
Jul 02, 2008 10:07AM
Keywords: MAXY

Movers roundup: Pier 1, Maxygen

Among the stock activity stories for Monday, June 16, from AP Financial News: NEW YORK (AP)--Shares of Pier 1 Imports Inc. rose Monday after Cost Plus Inc. rejected the home produc...READ MORE
Jun 16, 2008 2:38PM
Keywords: PIR, CPWM, MAXY, BRCM, SIRF

Maxygen edges up after patent-induced sell-off

(NEW YORK)Shares of Maxygen Inc. bounced back from a sharp decline, and an analyst said Monday that investors overreacted to a patent threat to its drug candidate MAXY-G34.READ MORE
Jun 16, 2008 12:11PM
Keywords: MAXY, AMGN

Maxygen plunges on potential Amgen patent dispute

(NEW YORK)Shares of Maxygen Inc. plunged 28 percent Friday, after the biotechnology company said it may be open to patent infringement litigation from rival Amgen Inc.READ MORE
Jun 13, 2008 7:35PM
Keywords: MAXY, AMGN

Maxygen warns of possible Amgen suit

(WASHINGTON)Maxygen Inc. warned Friday that Amgen Inc. may sue the company for patent infringement relating to Maxygen's Maxy-G34 drug candidate. Maxy-G34 is designed to be the improved ve...READ MORE
Jun 13, 2008 11:24AM
Keywords: MAXY, AMGN
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +28.80 60.41
AMYLIN PHARMA I -56.90 21.11
GILEAD SCIENCES +15.20 47.85
BIOGEN IDEC INC -20.40 48.59
GENENTECH INC +33.90 96.64